Breast

Papers
(The H4-Index of Breast is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Potential immune response to breast implants after immunization with COVID-19 vaccines1667
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?169
No association between breast pain and breast cancer121
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)118
SBRT AND NEW RADIOTHERAPY TECHNIQUES FOR METASTATIC DISEASE107
ADVANCED BREAST CANCER (ABC) PATIENT SUPPORT BY WEB CONFERENCING USING ZOOM99
A PATIENT’S JOURNEY: BRIDGING THE GAP FROM METASTATIC BREAST CANCER DIAGNOSIS TO ACTIVE INVOLVEMENT AS A PEER NAVIGATOR80
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS66
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?63
Editorial Board62
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?54
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer50
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer50
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery50
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction47
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT47
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience43
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY42
The continuing conundrum in oligometastatic breast carcinoma: A real-world data42
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis41
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes40
Response to comment on: “Global guidelines for breast cancer screening: A systematic review”39
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cance39
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers37
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain35
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology35
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer34
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study34
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis34
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer33
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions32
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients32
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines32
0.12819600105286